PSTX - Poseida Therapeutics GAAP EPS of -$0.45 misses by $0.03 revenue of $10.34M May, 09 2023 05:55 PM Poseida Therapeutics Inc. 2023-05-09 17:55:30 ET Poseida Therapeutics press release ( NASDAQ: PSTX ): Q1 GAAP EPS of -$0.45 misses by $0.03 . Revenue of $10.34M (+618.1% Y/Y). For further details see: Poseida Therapeutics GAAP EPS of -$0.45 misses by $0.03, revenue of $10.34M